Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Birnie, Matthew ^a   Morrison, Ryan ^a   Camara, Ramatoulie ^a   Strauss, Kenneth I ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Arachidonic acid metabolic genes; Cytochrome P450 genes; Hippocampus; In situ hybridization; Parietal cortex; QPCR low density array

Indexed keywords

ARACHIDONIC ACID; ARACHIDONIC ACID MONOOXYGENASE; CYTOCHROME P450; ICOSANOID; MESSENGER RNA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CYP GENE; FATTY ACID METABOLISM; GENE EXPRESSION; GENE IDENTIFICATION; HIPPOCAMPUS; HOUSEKEEPING GENE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARIETAL CORTEX; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HIPPOCAMPUS; MALE; MICE; PARIETAL LOBE; POLYMERASE CHAIN REACTION; RATS; RECOVERY OF FUNCTION; STEROIDS; TRANSCRIPTOME;

ARA; RATTUS;

EID: 84876960999     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-303     Document Type: Article

References (156)

1. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004, 14(1):1-18. 10.1097/00008571-200401000-00001, 15128046.
2. Kozak W, Kluger MJ, Kozak A, Wachulec M, Dokladny K. Role of cytochrome P-450 in endogenous antipyresis. Am J Physiol Regul Integr Comp Physiol 2000, 279(2):R455-R460.
3. McGiff JC, Carroll MA. Cytochrome P450-dependent arachidonate metabolites, renal function and blood pressure regulation. Adv Prostaglandin Thromboxane Leukot Res 1991, 21B:675-682.
4. Makita K, Falck JR, Capdevila JH. Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. FASEB J 1996, 10(13):1456-1463.
5. Fitzpatrick FA, Murphy RC. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol Rev 1988, 40(4):229-241.
6. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, Roman R. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol 1994, 266(5 Pt 2):H2098-H2107.
7. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000, 87(1):60-65. 10.1161/01.RES.87.1.60, 10884373.
8. Yu M, Cambj-Sapunar L, Kehl F, Maier KG, Takeuchi K, Miyata N, Ishimoto T, Reddy LM, Falck JR, Gebremedhin D. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol 2004, 486(3):297-306. 10.1016/j.ejphar.2004.01.009, 14985052.
9. Poloyac SM, Zhang Y, Bies RR, Kochanek PM, Graham SH. Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia. J Cereb Blood Flow Metab 2006, 26(12):1551-1561. 10.1038/sj.jcbfm.9600309, 16570075.
10. Imig JD, Simpkins AN, Renic M, Harder DR. Cytochrome P450 eicosanoids and cerebral vascular function. Expert Rev Mol Med 2011, 13:e7. 3613250, 21356152.
11. Ellis EF, Amruthesh SC, Police RJ, Yancey LM. Brain synthesis and cerebrovascular action of cytochrome P-450/monooxygenase metabolites of arachidonic acid. Adv Prostaglandin Thromboxane Leukot Res 1991, 21A:201-204.
12. Leffler CW, Fedinec AL. Newborn piglet cerebral microvascular responses to epoxyeicosatrienoic acids. Am J Physiol 1997, 273(1 Pt 2):H333-H338.
13. Peng X, Carhuapoma JR, Bhardwaj A, Alkayed NJ, Falck JR, Harder DR, Traystman RJ, Koehler RC. Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors. Am J Physiol Heart Circ Physiol 2002, 283(5):H2029-H2037.
14. Iliff JJ, Close LN, Selden NR, Alkayed NJ. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat. Exp Physiol 2007, 92(4):653-658.
15. Zhang W, Otsuka T, Sugo N, Ardeshiri A, Alhadid YK, Iliff JJ, DeBarber AE, Koop DR, Alkayed NJ. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 2008, 39(7):2073-2078. 10.1161/STROKEAHA.107.508325, 2654189, 18369166.
16. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996, 78(3):415-423. 10.1161/01.RES.78.3.415, 8593700.
17. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR, Roman RJ. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol 1996, 270(1 Pt 2):R228-R237.
18. Wu SN, Li HF, Chiang HT. Actions of epoxyeicosatrienoic acid on large-conductance Ca(2+)-activated K(+) channels in pituitary GH(3) cells. Biochem Pharmacol 2000, 60(2):251-262. 10.1016/S0006-2952(00)00317-8, 10825470.
19. Qu W, Bradbury JA, Tsao CC, Maronpot R, Harry GJ, Parker CE, Davis LS, Breyer MD, Waalkes MP, Falck JR. Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J Biol Chem 2001, 276(27):25467-25479. 10.1074/jbc.M100545200, 11328810.
20. Kroetz DL, Zeldin DC. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 2002, 13(3):273-283. 10.1097/00041433-200206000-00007, 12045397.
21. Ferroni S, Valente P, Caprini M, Nobile M, Schubert P, Rapisarda C. Arachidonic acid activates an open rectifier potassium channel in cultured rat cortical astrocytes. J Neurosci Res 2003, 72(3):363-372. 10.1002/jnr.10580, 12692903.
22. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL, Hammock BD. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 2007, 82(1-4):42-49. 1904338, 17164131.
23. Iliff JJ, Fairbanks SL, Balkowiec A, Alkayed NJ. Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neurons. J Neurochem 2010, 115(6):1530-1542. 10.1111/j.1471-4159.2010.07059.x, 2996475, 20950340.
24. Higashimori H, Blanco VM, Tuniki VR, Falck JR, Filosa JA. Role of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ signaling in perivascular astrocytes. Am J Physiol Cell Physiol 2010, 299(5):C1068-C1078. 10.1152/ajpcell.00225.2010, 2980321, 20844244.
25. Campbell WB. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci 2000, 21(4):125-127. 10.1016/S0165-6147(00)01472-3, 10740283.
26. Chen JK, Capdevila J, Harris RC. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 2001, 21(18):6322-6331. 10.1128/MCB.21.18.6322-6331.2001, 87364, 11509673.
27. Node K, Huo YQ, Ruan XL, Yang BC, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999, 285:1276-1279. 10.1126/science.285.5431.1276, 2720027, 10455056.
28. Hampson AJ, Grimaldi M. 12-hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor. J Neurosci 2002, 22(1):257-264.
29. Abdu E, Bruun DA, Yang D, Yang J, Inceoglu B, Hammock BD, Alkayed NJ, Lein PJ. Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures. J Neurochem 2011, 117(4):632-642. 3081369, 21155804.
30. Brenneis C, Sisignano M, Coste O, Altenrath K, Fischer MJ, Angioni C, Fleming I, Brandes RP, Reeh PW, Woolf CJ. Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation. Mol Pain 2011, 7:78. 10.1186/1744-8069-7-78, 3195722, 21970373.
31. Inceoglu B, Wagner K, Schebb NH, Morisseau C, Jinks SL, Ulu A, Hegedus C, Rose T, Brosnan R, Hammock BD. Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP. Proc Natl Acad Sci U S A 2011, 108(12):5093-5097. 10.1073/pnas.1101073108, 3064364, 21383170.
32. Sisignano M, Park CK, Angioni C, Zhang DD, von Hehn C, Cobos EJ, Ghasemlou N, Xu ZZ, Kumaran V, Lu R. 5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminals. J Neurosci 2012, 32(18):6364-6372. 10.1523/JNEUROSCI.5793-11.2012, 3359875, 22553041.
33. Terashvili M, Tseng LF, Wu HE, Narayanan J, Hart LM, Falck JR, Pratt PF, Harder DR. Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol Exp Ther 2008, 326(2):614-622. 10.1124/jpet.108.136739, 2567871, 18492947.
34. Wagner K, Inceoglu B, Hammock BD. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. Prostaglandins Other Lipid Mediat 2011, 96(1-4):76-83. 3215909, 21854866.
35. Wei EP, Lamb RG, Kontos HA. Increased phospholipase C activity after experimental brain injury. J Neurosurg 1982, 56(5):695-698. 10.3171/jns.1982.56.5.0695, 7069482.
36. Homayoun P, Rodriguez deTurco EB, Parkins NE, Lane DC, Soblosky J, Carey ME, Bazan NG. Delayed phospholipid degradation in rat brain after traumatic brain injury. J Neurochem 1997, 69(1):199-205.
37. Phillis JW, O'Regan MH. A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res Brain Res Rev 2004, 44(1):13-47. 10.1016/j.brainresrev.2003.10.002, 14739001.
38. Pilitsis JG, Coplin WM, O'Regan MH, Wellwood JM, Diaz FG, Fairfax MR, Michael DB, Phillis JW. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. Neuroscience Letters 2003, 349(2):136-138. 10.1016/S0304-3940(03)00803-6, 12946571.
39. Kontos HA, Wei EP, Ellis EF, Dietrich WD, Povlishock JT. Prostaglandins in physiological and in certain pathological responses of the cerebral circulation. Fed Proc 1981, 40(8):2326-2330.
40. Adesuyi SA, Cockrell CS, Gamache DA, Ellis EF. Lipoxygenase metabolism of arachidonic acid in brain. J Neurochem 1985, 45(3):770-776. 10.1111/j.1471-4159.1985.tb04059.x, 3928809.
41. Shohami E, Shapira Y, Sidi A, Cotev S. Head injury induces increased prostaglandin synthesis in rat brain. J Cereb Blood Flow Metab 1987, 7(1):58-63. 10.1038/jcbfm.1987.8, 3468118.
42. Westcott JY, Murphy RC, Stenmark K. Eicosanoids in human ventricular cerebrospinal fluid following severe brain injury. Prostaglandins 1987, 34(6):877-887.
43. Ellis EF, Police RJ, Rice LY, Grabeel M, Holt S. Increased plasma PGE2, 6-keto-PGF1 alpha, and 12-HETE levels following experimental concussive brain injury. J Neurotrauma 1989, 6(1):31-37. 10.1089/neu.1989.6.31, 2502634.
44. Ohtsuki T, Matsumoto M, Hayashi Y, Yamamoto K, Kitagawa K, Ogawa S, Yamamoto S, Kamada T. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol 1995, 268(3 Pt 2):H1249-H1257.
45. Dhillon HS, Dose JM, Prasad MR. Regional generation of leukotriene C4 after experimental brain injury in anesthetized rats. J Neurotrauma 1996, 13(12):781-789. 10.1089/neu.1996.13.781, 9002063.
46. Lammers CH, Schweitzer P, Facchinetti P, Arrang JM, Madamba SG, Siggins GR, Piomelli D. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem 1996, 66(1):147-152.
47. Strauss KI, Barbe MF, Marshall RM, Raghupathi R, Mehta S, Narayan RK. Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. J Neurotrauma 2000, 17(8):695-711. [erratum appears in J Neurotrauma 2000 Nov;17(11):1115], 10.1089/089771500415436, 1456323, 10972245.
48. Kunz T, Marklund N, Hillered L, Oliw EH. Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat. J Neurotrauma 2002, 19(9):1051-1064. 10.1089/089771502760341965, 12482118.
49. Takemiya T, Matsumura K, Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem Int 2007, 51(2-4):112-120.
50. Wang Y, Zhao J, Kalsotra A, Turman CM, Grill RJ, Dash PK, Strobel HW. CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury. J Neurotrauma 2008, 25(10):1187-1194. 10.1089/neu.2008.0542, 2948471, 18847377.
51. Gopez JJ, Yue H, Vasudevan R, Malik AS, Fogelsanger LN, Lewis S, Panikashvili D, Shohami E, Jansen SA, Narayan RK. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 2005, 56(3):590-604. 10.1227/01.NEU.0000154060.14900.8F, 1513642, 15730585.
52. Imaoka S, Hashizume T, Funae Y. Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab Pharmacokinet 2005, 20(6):478-484. 10.2133/dmpk.20.478, 16415532.
53. Liu M, Alkayed NJ. Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1alpha-linked induction of P450 2C11 epoxygenase in astrocytes. J Cereb Blood Flow Metab 2005, 25(8):939-948. 10.1038/sj.jcbfm.9600085, 15729289.
54. Poloyac SM, Reynolds RB, Yonas H, Kerr ME. Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage. J Neurosci Methods 2005, 144(2):257-263. 10.1016/j.jneumeth.2004.11.015, 15910986.
55. Sarkar P, Narayanan J, Harder DR. Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain. Neuroscience 2011, 194:241-249. 3183272, 21843605.
56. Ruparel S, Henry MA, Akopian A, Patil M, Zeldin DC, Roman L, Hargreaves KM. Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation. Pain 2012, 153(10):2031-2039. 10.1016/j.pain.2012.04.027, 22633978.
57. Strauss KI, Gruzdev A, Zeldin DC. Improved functional recovery in soluble epoxide hydrolase knockout mice after traumatic brain injury. Prostaglandins Other Lipid Mediat 2012, in press.
58. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004, 428(6982):493-521.
59. Ruparel S, Green D, Chen P, Hargreaves KM. The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain. Mol Pain 2012, 8:73. 10.1186/1744-8069-8-73, 3488501, 23006841.
60. Ellis EF, Wright KF, Wei EP, Kontos HA. Cyclooxygenase products of arachidonic acid metabolism in cat cerebral cortex after experimental concussive brain injury. J Neurochem 1981, 37(4):892-896. 10.1111/j.1471-4159.1981.tb04476.x, 6798171.
61. Nagayama M, Niwa K, Nagayama T, Ross ME, Iadecola C. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 1999, 19(11):1213-1219.
62. Dash P, Mach S, Moore A. Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury. J Neurotrauma 2000, 17:69-81. 10.1089/neu.2000.17.69, 10674759.
63. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A 2001, 98(3):1294-1299. 10.1073/pnas.98.3.1294, 14748, 11158633.
64. Candelario-Jalil E, Alvarez D, Castaneda JM, Al-Dalain SM, Martinez-Sanchez G, Merino N, Leon OS. The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils. Brain Res 2002, 927(2):212-215. 10.1016/S0006-8993(01)03358-3, 11821016.
65. Cernak I, O'Connor C, Vink R. Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp Brain Res 2002, 147(2):193-199. 10.1007/s00221-002-1245-z, 12410334.
66. Candelario-Jalil E, Mhadu NH, Gonzalez-Falcon A, Garcia-Cabrera M, Munoz E, Leon OS, Fiebich BL. Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat. J Neuroinflammation 2005, 2(1):3. 10.1186/1742-2094-2-3, 546225, 15656909.
67. Kelso ML, Scheff SW, Pauly JR, Loftin CD. Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice. BMC Neurosci 2009, 10:108. 10.1186/1471-2202-10-108, 2751761, 19719848.
68. Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, Zhang JH. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med 2009, in press.
69. Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, Zhang JH. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med 2010, 38(2):572-578. 10.1097/CCM.0b013e3181cb1158, 2808453, 20029340.
70. Malik AS, Narayan RK, Wendling WW, Cole RW, Pashko LL, Schwartz AG, Strauss KI. A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model. J Neurotrauma 2003, 20(5):463-476. 10.1089/089771503765355531, 1456324, 12803978.
71. Strauss KI, Meagher RJ, Narayan RK. Hippocampal prostaglandin changes following TBI- treatment with COX2 inhibitors. Restor Neurol Neurosci 2000, 16:263. P298.
72. Dewitt D, Kong D, Lyeth B, Jenkins L, Hayes R, Wooten E, Prough D. Experimental traumatic brain injury elevates brain prostaglandin E2 and thromboxane B2 levels in rats. J Neurotrauma 1988, 5:303-313. 10.1089/neu.1988.5.303, 3249309.
73. Yergey JA, Heyes MP. Brain eicosanoid formation following acute penetration injury as studied by in vivo microdialysis. J Cerebr Blood Flow Metabol 1990, 10(1):143-146.
74. Ermert L, Ermert M, Duncker HR, Grimminger F, Seeger W. In situ localization and regulation of thromboxane A(2) synthase in normal and LPS-primed lungs. Am J Physiol Lung Cell Mol Physiol 2000, 278(4):L744-L753.
75. McDonough W, Tran N, Giese A, Norman SA, Berens ME. Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 1998, 57(5):449-455. 10.1097/00005072-199805000-00008, 9596415.
76. Levi G, Minghetti L, Aloisi F. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 1998, 80(11):899-904. 10.1016/S0300-9084(00)88886-0, 9893949.
77. Ramamurthy S, Mir F, Gould RM, Le Breton GC. Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression. J Neurosci Res 2006, 84(7):1402-1414. 10.1002/jnr.21061, 16998891.
78. McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 2004, 24(1):257-268. 10.1523/JNEUROSCI.4485-03.2004, 14715958.
79. Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, Andreasson K. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J Immunol 2010, 184(12):7207-7218. 10.4049/jimmunol.0903487, 3103215, 20483760.
80. Zhang J, Rivest S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci 1999, 11(8):2651-2668. 10.1046/j.1460-9568.1999.00682.x, 10457163.
81. Bazan NG, Rodriguez de Turco EB, Allan G. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J Neurotrauma 1995, 12(5):791-814. 10.1089/neu.1995.12.791, 8594208.
82. Leslie JB, Watkins WD. Eicosanoids in the central nervous system. J Neurosurg 1985, 63(5):659-668. 10.3171/jns.1985.63.5.0659, 2997413.
83. Phillis JW, Horrocks LA, Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Res Rev 2006, 52(2):201-243. 10.1016/j.brainresrev.2006.02.002, 16647138.
84. Ashkar S, Mesentsev A, Zhang WX, Mastyugin V, Dunn MW, Laniado-Schwartzman M. Retinoic acid induces corneal epithelial CYP4B1 gene expression and stimulates the synthesis of inflammatory 12-hydroxyeicosanoids. J Ocul Pharmacol Ther 2004, 20(1):65-74. 10.1089/108076804772745473, 15006160.
85. Mastyugin V, Aversa E, Bonazzi A, Vafaes C, Mieyal P, Schwartzman ML. Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. J Pharmacol Exp Ther 1999, 289(3):1611-1619.
86. Canals S, Casarejos MJ, de Bernardo S, Rodriguez-Martin E, Mena MA. Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase. J Biol Chem 2003, 278(24):21542-21549. 10.1074/jbc.M213174200, 12679339.
87. Chiba Y, Shimada A, Satoh M, Saitoh Y, Kawamura N, Hanai A, Keino H, Ide Y, Shimizu T, Hosokawa M. Sensory system-predominant distribution of leukotriene A4 hydrolase and its colocalization with calretinin in the mouse nervous system. Neuroscience 2006, 141(2):917-927. 10.1016/j.neuroscience.2006.04.012, 16716527.
88. Imaoka S, Wedlund PJ, Ogawa H, Kimura S, Gonzalez FJ, Kim HY. Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase. J Pharmacol Exp Ther 1993, 267(2):1012-1016.
89. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest 1999, 104(6):751-760. 10.1172/JCI7013, 408434, 10491410.
90. Qian L, Zolfaghari R, Ross AC. Liver-specific cytochrome P450 CYP2C22 is a direct target of retinoic acid and a retinoic acid-metabolizing enzyme in rat liver. J Lipid Res 2010, 51(7):1781-1792. 10.1194/jlr.M002840, 2882718, 20147703.
91. Yu Z, Huse LM, Adler P, Graham L, Ma J, Zeldin DC, Kroetz DL. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. Mol Pharmacol 2000, 57(5):1011-1020.
92. Iliff JJ, Wang R, Zeldin DC, Alkayed NJ. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels. Am J Physiol Heart Circ Physiol 2009, 296(5):H1352-H1363. 10.1152/ajpheart.00950.2008, 2685348, 19304946.
93. Xu X, Zhang XA, Wang DW. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev 2011, 63(8):597-609. 10.1016/j.addr.2011.03.006, 21477627.
94. Bolbrinker J, Beige J, Huber M, Sharma A, Thomas A, Deter H, Kreutz R. Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men. J Hypertens 2011, 29(1):56-61. 10.1097/HJH.0b013e32833f5de5, 20852447.
95. Camara NO, Martins JO, Landgraf RG, Jancar S. Emerging roles for eicosanoids in renal diseases. Curr Opin Nephrol Hypertens 2009, 18(1):21-27. 10.1097/MNH.0b013e32831a9df7, 19077685.
96. Capdevila JH. Regulation of ion transport and blood pressure by cytochrome p450 monooxygenases. Curr Opin Nephrol Hypertens 2007, 16(5):465-470. 10.1097/MNH.0b013e32827ab48c, 17693763.
97. Simpson AE. The cytochrome P450 4 (CYP4) family. Gen Pharmacol 1997, 28(3):351-359. 10.1016/S0306-3623(96)00246-7, 9068972.
98. Ying CJ, Noguchi T, Aso H, Ikeda K, Yamori Y, Nara Y. The role of cytochrome p-450 in salt-sensitive stroke in stroke-prone spontaneously hypertensive rats. Hypertens Res 2008, 31(9):1821-1827. 10.1291/hypres.31.1821, 18971561.
99. Zhang F, Qian JQ, Wang DW. Arachidonate CYP hydroxylases of kidney contribute to formation of hypertension and maintenance of blood pressure. Acta Pharmacol Sin 2002, 23(6):497-502.
100. Dunn KM, Renic M, Flasch AK, Harder DR, Falck J, Roman RJ. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2008, 295(6):H2455-H2465. 10.1152/ajpheart.00512.2008, 2614536, 18952718.
101. Wang MH, Guan H, Nguyen X, Zand BA, Nasjletti A, Laniado-Schwartzman M. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am J Physiol 1999, 276(2 Pt 2):F246-F253.
102. Hoch U, Zhang Z, Kroetz DL, Ortiz de Montellano PR. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch Biochem Biophys 2000, 373(1):63-71. 10.1006/abbi.1999.1504, 10620324.
103. Zhang F, Chen CL, Qian JQ, Yan JT, Cianflone K, Xiao X, Wang DW. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. Cell Res 2005, 15(9):717-724. 10.1038/sj.cr.7290341, 16212878.
104. Zhang QY, Ding X, Kaminsky LS. CDNA cloning, heterologous expression, and characterization of rat intestinal CYP2J4. Arch Biochem Biophys 1997, 340(2):270-278. 10.1006/abbi.1997.9922, 9143331.
105. Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J Biol Chem 2004, 279(8):6305-6314.
106. Kawashima H, Kusunose E, Thompson CM, Strobel HW. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch Biochem Biophys 1997, 347(1):148-154. 10.1006/abbi.1997.0342, 9344476.
107. Xu F, Falck JR, Ortiz de Montellano PR, Kroetz DL. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. J Pharmacol Exp Ther 2004, 308(3):887-895.
108. Christmas P, Tolentino K, Primo V, Berry KZ, Murphy RC, Chen M, Lee DM, Soberman RJ. Cytochrome P-450 4F18 is the leukotriene B4 omega-1/omega-2 hydroxylase in mouse polymorphonuclear leukocytes: identification as the functional orthologue of human polymorphonuclear leukocyte CYP4F3A in the down-regulation of responses to LTB4. J Biol Chem 2006, 281(11):7189-7196. 10.1074/jbc.M513101200, 16380383.
109. Mezentsev A, Mastyugin V, Seta F, Ashkar S, Kemp R, Reddy DS, Falck JR, Dunn MW, Laniado-Schwartzman M. Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels. J Pharmacol Exp Ther 2005, 315(1):42-50. 10.1124/jpet.105.088211, 16009741.
110. Clark RS, Kochanek PM, Dixon CE, Chen M, Marion DW, Heineman S, DeKosky ST, Graham SH. Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. J Neurotrauma 1997, 14(4):179-189. 10.1089/neu.1997.14.179, 9151767.
111. Conti AC, Raghupathi R, Trojanowski JQ, McIntosh TK. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 1998, 18(15):5663-5672.
112. Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000, 17(10):927-938. 10.1089/neu.2000.17.927, 11063058.
113. Bylund J, Zhang C, Harder DR. Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem Biophys Res Commun 2002, 296(3):677-684. 10.1016/S0006-291X(02)00918-X, 12176035.
114. Stark K, Dostalek M, Guengerich FP. Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J 2008, 275(14):3706-3717. 10.1111/j.1742-4658.2008.06518.x, 18549450.
115. Snider NT, Walker VJ, Hollenberg PF. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacol Rev 2010, 62(1):136-154. 10.1124/pr.109.001081, 2835397, 20133390.
116. Hansen HS. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp Neurol 2010, 224(1):48-55. 10.1016/j.expneurol.2010.03.022, 20353771.
117. Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R. Endocannabinoids and traumatic brain injury. Br J Pharmacol 2011, 163(7):1402-1410. 10.1111/j.1476-5381.2011.01343.x, 3165950, 21418185.
118. Mateos L, Ismail MA, Gil-Bea FJ, Schule R, Schols L, Heverin M, Folkesson R, Bjorkhem I, Cedazo-Minguez A. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. J Biol Chem 2011, 286(29):25574-25585. 10.1074/jbc.M111.236877, 3138324, 21628469.
119. Shaw PM, Adesnik M, Weiss MC, Corcos L. The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU486. Mol Pharmacol 1993, 44(4):775-783.
120. Rifkind AB, Lee C, Chang TK, Waxman DJ. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 1995, 320(2):380-389. 10.1016/0003-9861(95)90023-3, 7625847.
121. Bylund J, Kunz T, Valmsen K, Oliw EH. Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. J Pharmacol Exp Ther 1998, 284(1):51-60.
122. Michaelis UR, Fisslthaler B, Barbosa-Sicard E, Falck JR, Fleming I, Busse R. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci 2005, 118(Pt 23):5489-5498.
123. Laethem RM, Balazy M, Falck JR, Laethem CL, Koop DR. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem 1993, 268(17):12912-12918.
124. Tindberg N, Ingelman-Sundberg M. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system. J Neurochem 1996, 67(5):2066-2073.
125. Nissbrandt H, Bergquist F, Jonason J, Engberg G. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?. Synapse 2001, 40(4):294-301. 10.1002/syn.1052, 11309845.
126. Bromek E, Haduch A, Daniel WA. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study. Eur J Pharmacol 2010, 626(2-3):171-178.
127. Bromek E, Haduch A, Golembiowska K, Daniel WA. Cytochrome P450 mediates dopamine formation in the brain in vivo. J Neurochem 2011, 118(5):806-815. 10.1111/j.1471-4159.2011.07339.x, 21651557.
128. McIntosh TK, Yu T, Gennarelli TA. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem 1994, 63(4):1426-1433.
129. Hernandez RE, Putzke AP, Myers JP, Margaretha L, Moens CB. Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development. Development 2007, 134(1):177-187. 10.1242/dev.02706, 1765950, 17164423.
130. Gonzalez-Quevedo R, Lee Y, Poss KD, Wilkinson DG. Neuronal regulation of the spatial patterning of neurogenesis. Dev Cell 2010, 18(1):136-147. 10.1016/j.devcel.2009.11.010, 2822724, 20152184.
131. Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, Yashiro K, Chawengsaksophak K, Wilson MJ, Rossant J. Retinoid signaling determines germ cell fate in mice. Science 2006, 312(5773):596-600. 10.1126/science.1125691, 16574820.
132. Wang C, Kane MA, Napoli JL. Multiple retinol and retinal dehydrogenases catalyze all-trans-retinoic acid biosynthesis in astrocytes. J Biol Chem 2011, 286(8):6542-6553. 10.1074/jbc.M110.198382, 3283052, 21138835.
133. Hagglund M, Berghard A, Strotmann J, Bohm S. Retinoic acid receptor-dependent survival of olfactory sensory neurons in postnatal and adult mice. J Neurosci 2006, 26(12):3281-3291. 10.1523/JNEUROSCI.4955-05.2006, 16554478.
134. Gilep AA, Sushko TA, Usanov SA. At the crossroads of steroid hormone biosynthesis: the role, substrate specificity and evolutionary development of CYP17. Biochim Biophys Acta 2011, 1814(1):200-209. 10.1016/j.bbapap.2010.06.021, 20619364.
135. Hojo Y, Hattori TA, Enami T, Furukawa A, Suzuki K, Ishii HT, Mukai H, Morrison JH, Janssen WG, Kominami S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci U S A 2004, 101(3):865-870. 10.1073/pnas.2630225100, 321772, 14694190.
136. Kibaly C, Patte-Mensah C, Mensah-Nyagan AG. Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J Neurochem 2005, 93(5):1220-1230. 10.1111/j.1471-4159.2005.03113.x, 15934942.
137. Kimoto T, Ishii H, Higo S, Hojo Y, Kawato S. Semicomprehensive analysis of the postnatal age-related changes in the mRNA expression of sex steroidogenic enzymes and sex steroid receptors in the male rat hippocampus. Endocrinology 2010, 151(12):5795-5806. 10.1210/en.2010-0581, 21047951.
138. García-Estrada J, Luquin S, Fernandez AM, Garcia-Segura LM. Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int J Dev Neurosci 1999, 17(2):145-151. 10.1016/S0736-5748(98)00065-3, 10221674.
139. Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000, 17(5):367-388. 10.1089/neu.2000.17.367, 10833057.
140. Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 2003, 6(1):13-22.
141. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004, 189(2):404-412. 10.1016/j.expneurol.2004.06.008, 15380490.
142. Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs 2010, 19(7):847-857. 10.1517/13543784.2010.489549, 20486864.
143. Hoffman SW, Virmani S, Simkins RM, Stein DG. The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J Neurotrauma 2003, 20(9):859-870. 10.1089/089771503322385791, 14577864.
144. Li Z, Cui S, Zhang Z, Zhou R, Ge Y, Sokabe M, Chen L. DHEA-neuroprotection and -neurotoxicity after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 2009, 29(2):287-296. 10.1038/jcbfm.2008.118, 18854841.
145. Tehranipour M, Moghimi A. Neuroprotective effects of testosterone on regenerating spinal cord motoneurons in rats. J Mot Behav 2010, 42(3):151-155. 10.1080/00222891003697921, 20363715.
146. Nguyen TV, Jayaraman A, Quaglino A, Pike CJ. Androgens selectively protect against apoptosis in hippocampal neurones. J Neuroendocrinol 2010, 22(9):1013-1022. 10.1111/j.1365-2826.2010.02044.x, 2924915, 20561156.
147. Toung TJ, Traystman RJ, Hurn PD. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 1998, 29(8):1666-1670. 10.1161/01.STR.29.8.1666, 9707210.
148. Garcia-Segura LM, Naftolin F, Hutchison JB, Azcoitia I, Chowen JA. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair [99 refs]. J Neurobiol 1999, 40(4):574-584. 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8, 10453057.
149. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 2003, 23(25):8701-8705.
150. Li J, Siegel M, Yuan M, Zeng Z, Finnucan L, Persky R, Hurn PD, McCullough LD. Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab 2011, 31(2):413-425. 10.1038/jcbfm.2010.181, 3049534, 20940729.
151. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55(4):611-622. 10.1373/clinchem.2008.112797, 19246619.
152. Yuan JS, Reed A, Chen F, Stewart CN. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7:85. 10.1186/1471-2105-7-85, 1395339, 16504059.
153. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
154. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3(6):1101-1108. 10.1038/nprot.2008.73, 18546601.
155. Paxinos G, Watson C. The rat brain in stereotaxic coordinates 1986, San Diego: Academic.
156. Strauss K, Jacobowitz D. Quantitative measurement of calretinin and b-actin mRNA in rat brain micropunches without prior isolation of RNA. Mol Brain Res 1993, 20(3):229-239. 10.1016/0169-328X(93)90045-Q, 8302161.